PGELX
Price
$28.10
Change
+$0.21 (+0.75%)
Updated
Sep 4 closing price
Net Assets
2.25B
RLBAX
Price
$37.59
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

PGELX vs RLBAX

Header iconPGELX vs RLBAX Comparison
Open Charts PGELX vs RLBAXBanner chart's image
George Putnam Balanced R5
Price$28.10
Change+$0.21 (+0.75%)
VolumeN/A
Net Assets2.25B
American Funds American Balanced R1
Price$37.59
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
PGELX vs RLBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGELX vs. RLBAX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGELX is a Buy and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 258B vs. PGELX (2.25B). PGELX pays higher dividends than RLBAX: PGELX (1.62) vs RLBAX (1.15). PGELX was incepted earlier than RLBAX: PGELX (12 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than PGELX (0.71). PGELX is a more actively managed with annual turnover of: 80.00 vs. RLBAX (44.00). PGELX has a lower initial minimum investment than RLBAX: PGELX (0) vs RLBAX (250). PGELX annual gain was more profitable for investors over the last year : 10.08 vs. RLBAX (9.12). RLBAX return over 5 years is better than : 35.40 vs. PGELX (33.01).
PGELXRLBAXPGELX / RLBAX
Total Expense Ratio0.711.3154%
Annual Report Gross Expense Ratio0.711.3154%
Fund Existence12 years23 years-
Gain YTD8.93610.80583%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B258B1%
Annual Yield % from dividends1.621.15141%
Returns for 1 year10.089.12110%
Returns for 3 years44.8737.15121%
Returns for 5 years33.0135.4093%
Returns for 10 years94.9067.71140%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNLI15.430.64
+4.33%
Denali Therapeutics
AUNA6.36N/A
N/A
Auna SA
QNRX7.56-0.06
-0.85%
Quoin Pharmaceuticals Ltd
STN108.05-1.24
-1.13%
Stantec
FATN5.86-0.29
-4.72%
FatPipe Inc.